Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone Addition in SRI-Resistant OCD
NCT00632229Phase 2Completed
- Sponsor
- University of South Florida
- Start
- Oct 2007
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paliperidone in obsessive compulsive disorder (OCD), sponsored by University of South Florida. Started Oct 2007; status: completed.
02
Drugs
paliperidone
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT00632229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00632229.